UK Markets closed
  • NIKKEI 225

    26,739.03
    +336.19 (+1.27%)
     
  • HANG SENG

    20,717.24
    +596.56 (+2.96%)
     
  • CRUDE OIL

    110.35
    +0.46 (+0.42%)
     
  • GOLD FUTURES

    1,845.10
    +3.90 (+0.21%)
     
  • DOW

    31,261.90
    +8.77 (+0.03%)
     
  • BTC-GBP

    23,556.00
    +151.62 (+0.65%)
     
  • CMC Crypto 200

    650.34
    -23.03 (-3.42%)
     
  • Nasdaq

    11,354.62
    -33.88 (-0.30%)
     
  • ^FTAS

    4,083.84
    +44.90 (+1.11%)
     

Novo Nordisk – major shareholder announcement

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·5-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
Novo Nordisk A/S
Novo Nordisk A/S

Bagsværd, Denmark, 2 May 2022 – Novo Nordisk today announced that the company has been notified by BlackRock, Inc. (Blackrock) as follows:

Blackrock holds as of 25 April 2022 B shares equal to 4.99% of the entire share capital of Novo Nordisk. The total B shares according to section 38 of the Danish Capital Markets Act, and other financial instruments according to section 39(2)(1) of the Danish Capital Markets Act and financial instruments with similar effects according to section 39(2)(2) of the Danish Capital Markets Act held by Blackrock correspond to 5.00% of the entire share capital and below 5% of the voting rights.

Blackrock holds as of 26 April 2022 B shares equal to below 5% of the entire share capital of Novo Nordisk. The total B shares according to section 38 of the Danish Capital Markets Act, and other financial instruments according to section 39(2)(1) of the Danish Capital Markets Act and financial instruments with similar effects according to section 39(2)(2) of the Danish Capital Markets Act held by Blackrock correspond to below 5% of the entire share capital and below 5% of the voting rights.

Blackrock holds as of 27 April 2022 B shares equal to 4.99% of the entire share capital of Novo Nordisk. The total B shares according to section 38 of the Danish Capital Markets Act, and other financial instruments according to section 39(2)(1) of the Danish Capital Markets Act and financial instruments with similar effects according to section 39(2)(2) of the Danish Capital Markets Act held by Blackrock correspond to 5.00% of the entire share capital and below 5% of the voting rights.

The announcement is in accordance with section 30 of the Danish Capital Markets Act.

For a full chain of controlled undertakings through which the voting rights and/or the financial instruments are held, please see the annexes.

About Novo Nordisk
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure disease. Novo Nordisk employs about 49,300 people in 80 countries and markets its products in around 170 countries. Novo Nordisk's B shares are listed on Nasdaq Copenhagen (Novo-B). Its ADRs are listed on the New York Stock Exchange (NVO). or more information, visit novonordisk.com, Facebook, Twitter, LinkedIn and YouTube.

Further information

Media:

Ambre Brown Morley

+45 3079 9289

abmo@novonordisk.com

Natalia Salomao Abrahao (US)

+1 848 304 1027

niaa@novonordisk.com

Investors:

Daniel Muusmann Bohsen

+45 3075 2175

dabo@novonordisk.com

Ann Søndermølle Rendbæk

+45 3075 2253

arnd@novonordisk.com

David Heiberg Landsted

+45 3077 6915

dhel@novonordisk.com

Jacob Martin Wiborg Rode

+45 3075 5956

jrde@novonordisk.com

Mark Joseph Root (US)

+1 848 213 3219

mjhr@novonordisk.com

Company announcement No 37 / 2022

Annex 1: Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity as of 25 April 2022

Name

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

BlackRock Japan Co., Ltd.

Below 5%

BlackRock Investment Management, LLC

Below 5%

BlackRock Investment Management (UK) Limited

Below 5%

BlackRock Investment Management (Australia) Limited

Below 5%

BlackRock International Limited

Below 5%

BlackRock Institutional Trust Company, National Association

Below 5%

BlackRock Fund Advisors

Below 5%

BlackRock Financial Management, Inc.

Below 5%

BlackRock Asset Management North Asia Limited

Below 5%

BlackRock Asset Management Deutschland AG

Below 5%

BlackRock Asset Management Canada Limited

Below 5%

BlackRock Advisors, LLC

Below 5%

BlackRock Advisors (UK) Limited

Below 5%

BlackRock (Singapore) Limited

Below 5%

BlackRock Asset Management Ireland Limited

Below 5%

Aperio Holdings, LLC

Below 5%

Annex 2: Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity as of 26 April 2022

Name

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

BlackRock Japan Co., Ltd.

Below 5%

BlackRock Investment Management, LLC

Below 5%

BlackRock Investment Management (UK) Limited

Below 5%

BlackRock Investment Management (Australia) Limited

Below 5%

BlackRock International Limited

Below 5%

BlackRock Institutional Trust Company, National Association

Below 5%

BlackRock Fund Advisors

Below 5%

BlackRock Financial Management, Inc.

Below 5%

BlackRock Asset Management North Asia Limited

Below 5%

BlackRock Asset Management Deutschland AG

Below 5%

BlackRock Asset Management Canada Limited

Below 5%

BlackRock Advisors, LLC

Below 5%

BlackRock Advisors (UK) Limited

Below 5%

BlackRock (Singapore) Limited

Below 5%

BlackRock Asset Management Ireland Limited

Below 5%

Aperio Holdings, LLC

Below 5%

Annex 3: Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity as of 27 April 2022

Name

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

BlackRock Japan Co., Ltd.

Below 5%

BlackRock Investment Management, LLC

Below 5%

BlackRock Investment Management (UK) Limited

Below 5%

BlackRock Investment Management (Australia) Limited

Below 5%

BlackRock International Limited

Below 5%

BlackRock Institutional Trust Company, National Association

Below 5%

BlackRock Fund Advisors

Below 5%

BlackRock Financial Management, Inc.

Below 5%

BlackRock Asset Management North Asia Limited

Below 5%

BlackRock Asset Management Deutschland AG

Below 5%

BlackRock Asset Management Canada Limited

Below 5%

BlackRock Advisors, LLC

Below 5%

BlackRock Advisors (UK) Limited

Below 5%

BlackRock (Singapore) Limited

Below 5%

BlackRock Asset Management Ireland Limited

Below 5%

Aperio Holdings, LLC

Below 5%

Attachment


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting